Table 4.
Risk Factors for Pain in Cancer Patients at AUBMC
Unadjusted OR (95%CI) | P | Adjusted OR (95% CI) | P | |
---|---|---|---|---|
Age | 0.99 (0.98-1.01) | 0.23 | 0.99 (0.98-1.01) | 0.56 |
Gender | ||||
Male | 1.00 | 0.001* | 1.00 | 0.03* |
Female | 2.18 (1.35-3.51) | 1.97 (1.07-3.62) | ||
Type of residency | ||||
Urban | 1.00 | 0.03* | 1.00 | 0.04* |
Rural | 1.90 (1.07-3.38) | 1.89 (1.04-3.44) | ||
Cancer site | ||||
Breast | 1.00 | 0.02* | 1.00 | 0.10 |
Lungs | 0.48 (0.15-1.52) | 0.21 | 0.78 (0.23-2.71) | 0.7 |
Colon | 0.23 (0.09-0.58) | 0.002* | 0.36 (0.14-0.94) | 0.04* |
Non-colon gastrointestinal | 0.55 (0.29-1.03) | 0.06 | 0.77 (0.38-1.57) | 0.47 |
Hematology | 0.98 (0.50-1.94) | 0.96 | 1.71 (0.76-3.84) | 0.2 |
Other | 0.62 (0.32-1.18) | 0.14 | 0.89 (0.43-1.83) | 0.75 |
Education | ||||
Below university level | 1.00 | 0.94 | ||
University level | 0.98 (0.62-1.55) | |||
Cancer stage | ||||
Stage I | 1.00 | 0.14 | ||
Stage II | 0.67 (0.22-2.05) | 0.49 | ||
Stage III | 0.73 (0.24-2.22) | 0.57 | ||
Stage IV | 0.43 (0.15-1.22) | 0.11 | ||
Type of treatment | ||||
Surgery | 1.00 | 0.28 | ||
Systemic therapy | 0.30 (0.05-1.85) | 0.20 | ||
Surgery + systemic therapy | 0.25 (0.04-1.55) | 0.14 |
pvalue≤0.05